Dyadic Reports 2023 Full Year Results and Recent Company Progress
March 28, 2024 16:00 ET
|
Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...
Dyadic to Attend Industry Events in April
March 27, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
March 20, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announces today that it has extended the exclusivity period on...
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
March 14, 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building...
Dyadic to Attend Industry Events in March
March 01, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. , March 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Animal Disinfectants Market with Remarkable Share by 2028
March 01, 2024 03:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, March 01, 2024 (GLOBE NEWSWIRE) -- The Animal Disinfectants Market refers to the sector of the economy that involves the production, distribution, and sale of disinfectant products...
Amlan International establece una asociación estratégica con Grupo Profil como su más reciente distribuidor en América Latina, ampliando el acceso a soluciones innovadoras para la salud intestinal en la industria pecuaria
February 28, 2024 17:00 ET
|
Oil-Dri Corporation Of America
CHICAGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Amlan International, la división de salud animal de Oil-Dri Corporation of America, se complace en anunciar su asociación con Grupo Profil, su más...
Amlan International Forges Strategic Partnership with Grupo Profil as its Newest Latin American Distributor, Amplifying Access to Innovative Gut Health Solutions for Protein Producers
February 28, 2024 17:00 ET
|
Oil-Dri Corporation Of America
CHICAGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Amlan® International, the animal health division of Oil-Dri® Corporation of America, is excited to announce its partnership with Grupo Profil as the newest...
Animal Drug Compounding Market Forecasted at $2.23 Billion by 2028, Fueled by Regulatory Shifts and Specialized Veterinary Care Trends
February 14, 2024 09:31 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Animal Drug Compounding Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global animal drug compounding...
Amlan International Partners with KOFARM to Showcase Gut Health Solutions for Swine at AMVECAJ 2024
February 06, 2024 17:00 ET
|
Oil-Dri Corporation Of America
CHICAGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America, is pleased to announce its participation in the upcoming XXX AMVECAJ...